TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCC

NCT06236425 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinoma of Head and Neck
Metastatic Squamous Cell Carcinoma

Interventions

BIOLOGICAL: TBio-4101
DRUG: Pembrolizumab
DRUG: Platinum based chemotherapy
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Aldesleukin

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]